This site is intended for Healthcare professionals only.

Lupin gets USFDA approval for Mild Atopic dermatitis treatment lotion


Lupin gets USFDA approval for Mild Atopic dermatitis treatment lotion

New Delhi: Drug major Lupin recently stated it has received final approval from the United States Food and Drug Administration (USFDA) to market Hydrocortisone Butyrate lotion, used for the treatment of mild atopic dermatitis in patients 3 months of age and older, in the US market.

The approved product is a generic version of PreCision Dermatology, Inc.’s (PreCision) Locoid Lotion, 0.1 percent, Lupin said in a BSE filing.

Shares of Lupin were trading 0.77 percent higher at Rs 876.50 apiece on BSE.



Source: PTI
0 comment(s) on Lupin gets USFDA approval for Mild Atopic dermatitis treatment lotion

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted